Ausnutria Dairy Corporation Ltd

SEHK:1717 Stock Report

Market Cap: HK$3.6b

Ausnutria Dairy Valuation

Is 1717 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 1717 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1717 (HK$2.02) is trading below our estimate of fair value (HK$7.72)

Significantly Below Fair Value: 1717 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1717?

Key metric: As 1717 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 1717. This is calculated by dividing 1717's market cap by their current earnings.
What is 1717's PE Ratio?
PE Ratio24.8x
EarningsCN¥135.18m
Market CapCN¥3.40b

Price to Earnings Ratio vs Peers

How does 1717's PE Ratio compare to its peers?

The above table shows the PE ratio for 1717 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average48.2x
1458 Zhou Hei Ya International Holdings
70.9x53.3%HK$3.7b
6868 Tenfu (Cayman) Holdings
20.1xn/aHK$4.0b
6683 Star Plus Legend Holdings
85.9x33.5%HK$4.3b
6836 Tianyun International Holdings
15.8xn/aHK$3.2b
1717 Ausnutria Dairy
24.8x38.1%HK$3.6b

Price-To-Earnings vs Peers: 1717 is good value based on its Price-To-Earnings Ratio (24.8x) compared to the peer average (48.2x).


Price to Earnings Ratio vs Industry

How does 1717's PE Ratio compare vs other companies in the HK Food Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
809 Global Bio-chem Technology Group
0.2xn/aUS$91.52m
3889 Global Sweeteners Holdings
2.4xn/aUS$29.39m
No more companies available in this PE range
1717 24.8xIndustry Avg. 14.2xNo. of Companies8PE01020304050+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 1717 is expensive based on its Price-To-Earnings Ratio (24.8x) compared to the Hong Kong Food industry average (14.2x).


Price to Earnings Ratio vs Fair Ratio

What is 1717's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1717 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.8x
Fair PE Ratio22.5x

Price-To-Earnings vs Fair Ratio: 1717 is expensive based on its Price-To-Earnings Ratio (24.8x) compared to the estimated Fair Price-To-Earnings Ratio (22.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1717 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$2.02
HK$2.68
+32.9%
17.5%HK$3.15HK$2.21n/a2
Nov ’25HK$2.06
HK$2.68
+30.3%
17.5%HK$3.15HK$2.21n/a2
Oct ’25HK$2.36
HK$2.68
+13.7%
17.5%HK$3.15HK$2.21n/a2
Sep ’25HK$1.87
HK$3.07
+64.3%
21.4%HK$3.83HK$2.22n/a3
Aug ’25HK$1.93
HK$3.13
+62.2%
15.5%HK$3.74HK$2.55n/a3
Jul ’25HK$2.22
HK$3.08
+38.7%
16.0%HK$3.74HK$2.55n/a3
Jun ’25HK$2.32
HK$3.23
+39.1%
15.1%HK$3.76HK$2.56n/a4
May ’25HK$2.31
HK$3.23
+39.7%
15.1%HK$3.76HK$2.56n/a4
Apr ’25HK$2.35
HK$3.25
+38.3%
13.5%HK$3.76HK$2.57n/a5
Mar ’25HK$2.53
HK$3.36
+32.6%
15.7%HK$4.04HK$2.58n/a5
Feb ’25HK$2.43
HK$3.36
+38.1%
15.7%HK$4.04HK$2.58n/a5
Jan ’25HK$2.61
HK$3.70
+41.7%
12.7%HK$4.25HK$2.89n/a6
Dec ’24HK$2.70
HK$3.70
+37.0%
12.7%HK$4.25HK$2.89n/a6
Nov ’24HK$2.80
HK$3.70
+32.1%
12.7%HK$4.25HK$2.89HK$2.066
Oct ’24HK$2.89
HK$4.14
+43.3%
29.1%HK$6.90HK$2.87HK$2.367
Sep ’24HK$3.27
HK$4.21
+28.8%
31.1%HK$6.96HK$2.90HK$1.876
Aug ’24HK$3.50
HK$4.53
+29.4%
28.7%HK$7.04HK$3.34HK$1.935
Jul ’24HK$3.43
HK$4.91
+43.0%
29.7%HK$7.34HK$3.48HK$2.224
Jun ’24HK$3.42
HK$4.91
+43.4%
29.7%HK$7.34HK$3.48HK$2.324
May ’24HK$3.74
HK$5.10
+36.3%
31.9%HK$7.32HK$3.47HK$2.313
Apr ’24HK$3.83
HK$5.46
+42.6%
36.2%HK$7.49HK$3.47HK$2.354
Mar ’24HK$4.35
HK$7.36
+69.2%
44.5%HK$14.92HK$4.54HK$2.537
Feb ’24HK$4.43
HK$8.07
+82.2%
44.3%HK$15.36HK$4.68HK$2.437
Jan ’24HK$4.19
HK$7.71
+84.0%
41.6%HK$14.75HK$4.49HK$2.618
Dec ’23HK$4.17
HK$7.80
+87.1%
37.2%HK$14.41HK$5.36HK$2.708
Nov ’23HK$3.70
HK$8.01
+116.5%
34.9%HK$14.45HK$5.38HK$2.809

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies